Rachel Kuperman

2.5k citations
21 papers · 1.3k indexed · 1 hit paper · h-index 13
Topics
Tuberous Sclerosis Complex Research (9 papers)EEG and Brain-Computer Interfaces (5 papers)Neonatal and fetal brain pathology (4 papers)

In The Last Decade

Rachel Kuperman

20 papers receiving 1.3k citations

Hit Papers

Efficacy and safety of everolimus for subependymal giant ...20122026201620212012100200300400500

Peers

Rachel Kuperman
Comparison fields: 5 of 91
  • Physiology 644
  • Oncology 296
  • Molecular Biology 283
  • Cognitive Neuroscience 259
  • Pulmonary and Respiratory Medicine 205
Replace Katherine Holland with:
Katherine Holland United States
Yo Niida Japan
Stefan Wieczorek Germany
Daniel K. Miles United States
Kira A. Dies United States
Roberta Bombardieri Italy
R. Plasmati Italy
Greetje Vanhoutte Belgium
Anouk van der Hoorn Netherlands
Allyn McConkie‐Rosell United States
Rachel Kuperman relative to Katherine Holland United States Katherine Holland's profile →
Citations per field
00.5×1.5×2.1×
Katherine Holland · 1×
Citations per year

Countries citing papers authored by Rachel Kuperman

Since Specialization
Citations

This map shows the geographic impact of Rachel Kuperman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Kuperman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Kuperman more than expected).

Fields of papers citing papers by Rachel Kuperman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Kuperman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Kuperman. The network helps show where Rachel Kuperman may publish in the future.

Co-authorship network of co-authors of Rachel Kuperman

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Kuperman. A scholar is included among the top collaborators of Rachel Kuperman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Kuperman. Rachel Kuperman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 24
2 9
3 1
4 51
5 30
6 134
7 17
8 1
9 1
10 127
11 62
12 130
13 46
14 7
15
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialbreakdown →
578
16 18
17 3
18 22
19 47
20 3

About Rachel Kuperman

Rachel Kuperman is a scholar working on Cognitive Neuroscience, Physiology and Psychiatry and Mental health, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Tuberous Sclerosis Complex Research (9 papers), EEG and Brain-Computer Interfaces (5 papers) and Neonatal and fetal brain pathology (4 papers). The work is most often cited by research in Physiology (644 citations), Cognitive Neuroscience (259 citations) and Genetics (120 citations). Rachel Kuperman has collaborated with scholars based in United States, Poland and France. Frequent co-authors include Joyce Y. Wu, Е. Д. Белоусова, Sergiusz Jóźwiak, Steven Sparagana, Michael Kohrman, E. Martina Bebin, J. Robert Flamini, Michael Frost, David Neal Franz and Olaf Witt. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026